Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Vortioxetine
Drug ID BADD_D02371
Description Vortioxetine is an atypical antipsychotic and antidepressant indicated for the treatment of major depressive disorder (MDD). It is classified as a serotonin modulator and simulator (SMS) as it has a multimodal mechanism of action towards the serotonin neurotransmitter system whereby it simultaneously modulates one or more serotonin receptors and inhibits the reuptake of serotonin. More specifically, vortioxetine acts via the following biological mechanisms: as a serotonin reuptake inhibitor (SRI) through inhibition of the serotonin transporter, as a partial agonist of the 5-HT1B receptor, an agonist of 5-HT1A, and an antagonist of the 5-HT3, 5-HT1D, and 5-HT7 receptors. SMSs were developed because there are many different subtypes of serotonin receptors, however, not all of these receptors appear to be involved in the antidepressant effects of SRIs. Some serotonin receptors seem to play a relatively neutral or insignificant role in the regulation of mood, but others, such as 5-HT1A autoreceptors and 5-HT7 receptors, appear to play an oppositional role in the efficacy of SRIs in treating depression.
Indications and Usage Vortioxetine is indicated for the treatment of major depressive disorder (MDD).
Marketing Status Prescription; Discontinued
ATC Code N06AX26
DrugBank ID DB09068
KEGG ID D10184
MeSH ID D000078784
PubChem ID 9966051
TTD Drug ID D03WEX
NDC Product Code 47234-4105; 70518-2642; 47234-4110; 64764-750; 64764-720; 64764-730; 55154-0257; 55154-0256; 47234-4120
Synonyms Vortioxetine | 1-(2-(2,4-Dimethylphenylsulfanyl)phenyl)piperazine | Lu AA21004 | LuAA21004 | Lu-AA21004 | Brintellix | Vortioxetine Hydrobromide
Chemical Information
Molecular Formula C18H22N2S
CAS Registry Number 508233-74-7
SMILES CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Psychotic disorder19.03.01.0020.002094%
Renal impairment20.01.03.010--Not Available
Haemorrhagic diathesis24.07.01.020; 01.01.03.0030.001396%Not Available
Suicidal behaviour19.12.01.0060.003490%Not Available
Hypersexuality19.08.03.0050.001396%Not Available
Oral herpes11.05.02.005; 07.05.07.0020.002094%Not Available
Oropharyngeal pain22.02.05.022; 07.05.05.0040.002094%
Meige's syndrome17.01.02.0220.001396%Not Available
Tachyphrenia19.10.03.010; 17.03.03.0070.002094%Not Available
The 8th Page    First    Pre   8    Total 8 Pages